Lake Street Maintains Buy on Bioceres Crop Solutions, Lowers Price Target to $25
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Ben Klieve has maintained a 'Buy' rating on Bioceres Crop Solutions (NASDAQ:BIOX) but lowered the price target from $30 to $25.
September 12, 2023 | 3:21 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Despite the lowered price target, Lake Street's 'Buy' rating on Bioceres Crop Solutions (BIOX) remains unchanged.
The news is directly about BIOX and is important for investors as it provides an updated price target and reaffirms the 'Buy' rating. The impact on the stock price is neutral in the short term as the lowered price target might cause some investors to sell, but the maintained 'Buy' rating could also attract new investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100